Skip to main content
Clinical Trials/NCT02876367
NCT02876367CompletedNot Applicable

The Clinical Epidemiology of Scrub Typhus in Humans, Chiggers and Rodents

University of Oxford0 sites1,200 target enrollmentStarted: September 1, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
1,200
Primary Endpoint
Identify key mite vectors and rodent hosts involved in scrub typhus natural history, human infection, and disease virulence

Study Overview

Brief Summary

This study to collect and identify rodents and mites across transects through diverse habitats used by the human community from a localised area identified as a scrub typhus 'hot spot'.

Detailed Description

Study design:

The project will undertake a detailed investigation of one human community, and its environment, at risk of scrub typhus:

Chiggers, Rodents & Habitat Study:

Transects across diverse habitats determining spatial distribution of species of chiggers and rodents. This will be performed 3x/year.

High-resolution habitat mapping. Comparison of genomes of O. tsutsugamushi detected in different environments, using attempted WGS.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
10 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Acute scrub typhus (Group 1)
  • Presenting with fever >38 C and testing positive by scrub typhus RDT.
  • Male or Female, aged 10 years or above.
  • Participant is willing and able to give informed consent for participation in the study.
  • Scrub typhus serosurvey (Group 2)
  • Villagers living in an environment in which scrub typhus is known to be present, who are asymptomatic.
  • Male or Female, aged 10 years or above.
  • Participant is willing and able to give informed consent for participation in the study.

Exclusion Criteria

  • Acute scrub typhus (Group 1)
  • Villagers/patients under 10 years of age.
  • Those unwilling to give written informed consent.
  • Scrub typhus serosurvey (Group 2)
  • Villagers/patients under 10 years of age.
  • Those unwilling to give written informed consent.

Outcomes

Primary Outcomes

Identify key mite vectors and rodent hosts involved in scrub typhus natural history, human infection, and disease virulence

Time Frame: up to 24 months

determine the diversity of O. tsutsugamushi genotypes infecting rodents and mites and link these to their geographical distribution and associated habitat characteristics.

Time Frame: up to 24 months

Correlate the frequency of O. tsutsugamushi in mites and rodents with habitat characteristics, to define interactions between distribution and transmission dynamics.

Time Frame: up to 24 months

Secondary Outcomes

  • Identify human-derived O. tsutsugamushi genotypes to define genomic relationships between human, rodent and mite-derived genotypes.(up to 24 months)
  • To interlink the distribution of O. tsutsugamushi positive mites, rodents and humans with habitat characteristics to propose interventions to reduce the risk of human disease.(up to 24 months)
  • Identify putative determinants of human infection/virulence(up to 24 months)
  • Determine changes in scrub typhus antibody titres over time and identify acutely infected scrub typhus cases(up to 24 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials

The Clinical Epidemiology of Scrub Typhus... | Clinical Trial